🇺🇸 FDA
Pipeline program

Yishen Qutong Granules

NCC4369

Unknown small_molecule active

Quick answer

Yishen Qutong Granules for Esophageal Squamous Cell Carcinoma (ESCC) is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Esophageal Squamous Cell Carcinoma (ESCC)
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials